v3.26.1
Condensed Consolidated Statements of Operations (unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Revenue    
Total revenue $ 6,472 $ 14,745
Operating costs and expenses    
Cost of revenue 12,490 21,829
Research and development 87,896 129,634
General and administrative 34,591 54,650
Total operating costs and expenses 134,977 206,113
Loss from operations (128,505) (191,368)
Other income (loss), net 6,397 (11,277)
Loss before income tax benefit (122,108) (202,645)
Income tax benefit 4,604 158
Net loss $ (117,504) $ (202,487)
Per share data    
Net loss per share of class A, B and Exchangeable common stock, basic (in dollars per share) $ (0.22) $ (0.50)
Net loss per share of class A, B and Exchangeable common stock, diluted (in dollars per share) $ (0.22) $ (0.50)
Weighted-average shares (Class A, B and Exchangeable) outstanding, basic (in shares) 529,303,984 402,771,972
Weighted-average shares (Class A, B and Exchangeable) outstanding, diluted (in shares) 529,303,984 402,771,972
Operating revenue    
Revenue    
Total revenue $ 6,301 $ 14,818
Grant revenue    
Revenue    
Total revenue $ 171 $ (73)